The Division of Pulmonary Diseases & Critical Care Medicine at the University of North Carolina at Chapel Hill provides care and treatment for a wide range of respiratory diseases and critically ill patients. Our physicians conduct research related to a broad spectrum of lung diseases, interventional pulmonology, transplant medicine, and critical care medicine, and are also commitment to advancing the education of pulmonary and critical care physicians and scientists.
Pulmonary & Critical Care News
-
COVID-19 Reflections One Year Later
One year has passed since Governor Cooper declared a state of emergency for North Carolina due to the COVID-19 pandemic, and hospitals and health systems across the state had to pivot to take care of their patients. Jason Mock, MD, PhD, assistant professor of medicine in the division of pulmonary diseases and critical care medicine, … Continued
-
Antiviral Pill Could Alter the Fight Against COVID
The International Business Times reports on the drug molnupiravir, which has shown positive results in preliminary studies by significantly reducing infection of the virus in patients after five days of treatment. William Fischer, MD, associate professor of medicine in the division of pulmonary diseases and critical care medicine, and lead investigator of the study at … Continued
-
Can COVID-19 Be Treated With a Pill?
William Fischer, MD, associate professor of medicine in the division of pulmonary and critical care medicine, who led UNC trials to determine if Molnupiravir could be a possible treatment for COVID-19, was quoted in a CBS-17 News report about its potential to change the way COVID-19 is treated. “The secondary objective findings in this study, … Continued